Genoray Secures Consecutive Large-Scale Orders in Brazil and Russia (2026.02.03)

  Global X-ray imaging medical device specialist Genoray (CEO Park Byung-wook) has secured orders totaling 17 billion KRW in Brazil and Russia as of January 2026, 

achieving remarkable results in overseas markets. With a series of large-scale contracts confirmed, the company’s global order performance has 

entered a phase of full-scale expansion from the beginning of the year. The OSCAR15, the model involved in this order, is Genoray’s top-tier C-arm system, reflecting the company’s accumulated 

R&D expertise. According to the medical device industry, Brazil is considered a key market in the LATAM region. 

Genoray established its LATAM office in November 2025, and the subsequent large-scale order in Brazil in January is seen as a tangible result of its strategy to strengthen local sales operations.

  This order success is consistent with Genoray’s recent performance trends. Following a gradual increase in sales since the fourth quarter of last year, the company successfully closed a 

contract worth approximately 3 billion KRW in a Turkish tender at the end of the year. With the addition of the Brazil and Russian orders in early 2026, these are expected to contribute significantly to the annual performance. 

In particular, the Brazilian order is expected to go beyond a one-time success and lead to further large-scale opportunities from 2027 onwards. 

  Genoray was able to establish a bridgehead for overseas orders based on the FDA and ANVISA certifications obtained in 2025, and plans to aggressively expand the scope of tender-eligible countries based on the CE certification scheduled for 2026, 

translating this into revenue. Industry experts attribute these achievements to Genoray’s consistent R&D investment and its strategy of strengthening local sales responsiveness. 

A Genoray representative stated, "The success of large-scale orders since the second half of 2025 demonstrates the contribution of the sales and investment activities Genoray has accumulated in overseas markets," adding, 

"Our continuous R&D and global sales strategies are bearing fruit in the form of incremental achievements."